The glycosylsphingolipid psychosine has emerged as a biomarker for diagnosis and prognosis of Krabbe disease, a rare lysosomal storage disorder caused by deficiency of galactocerebrosidase (GALC) [1,2,3]. This evidence concerns the gene GALC and Krabbe disease.